Medical Oncology

Mednet Member

Medical Oncology · Taussig Cancer Institute

I think most would avoid induction-like chemotherapy opting for new regimens such as azacitidine + venetoclax. However, in many instances, the mutation panel comes back after you start treatment which provides a real challenge to use this infuriation in real-time. I hope that faster TAT on NGS panel...